HEPARIN SODIUM INJECTION, USP
HEPARIN SODIUM INJECTION, USP
Approved
DIN Number
02264307
Drug Class
Human
Market Date
May 27, 2005
Company
HC
fresenius kabi canada ltd
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02264307
AIG Number0104596002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
B01AB01 HEPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
,
Intravenous
AHFS Classification20:12.04.16
Health Canada Classification
ACTIVE INGREDIENTS (1)
HEPARIN SODIUMActive
Strength: 10000 UNIT / ML
Monograph: HEPARIN SODIUM